Manage the Biologic Dupilumab During a Hospital Stay

July 2022

New uses will spur questions about managing the injectable dupilumab (Dupixent) when patients are admitted.

It’s now approved for eosinophilic esophagitis...and its moderate to severe eczema indication is expanded down to age 6 months. Or you may see it used for asthma or chronic sinusitis with nasal polyps.

Dupilumab is an immunomodulator that reduces inflammation. This is similar to other monoclonal antibodies for asthma or atopic dermatitis...omalizumab (Xolair), tralokinumab (Adbry), etc.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote